secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001213900-25-061936
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive regains Nasdaq minimum bid price compliance after reverse split
-------------------------------------------------------------------------

- Regained compliance with Nasdaq minimum bid price of $1.00 per share.
- Nasdaq notified the company on July 7, 2025, confirming compliance as of July 3, 2025.
- Compliance achieved after a 1:10 reverse stock split effective June 20, 2025.
- The matter is now closed by Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025061936/0001213900-25-061936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025061936/ea0248322-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-061936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer